1. Home
  2. YYAI vs CTXR Comparison

YYAI vs CTXR Comparison

Compare YYAI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YYAI
  • CTXR
  • Stock Information
  • Founded
  • YYAI 2015
  • CTXR 2007
  • Country
  • YYAI Hong Kong
  • CTXR United States
  • Employees
  • YYAI N/A
  • CTXR N/A
  • Industry
  • YYAI
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • YYAI
  • CTXR Health Care
  • Exchange
  • YYAI NYSE
  • CTXR Nasdaq
  • Market Cap
  • YYAI 13.7M
  • CTXR 14.6M
  • IPO Year
  • YYAI N/A
  • CTXR N/A
  • Fundamental
  • Price
  • YYAI $0.90
  • CTXR $2.10
  • Analyst Decision
  • YYAI
  • CTXR Strong Buy
  • Analyst Count
  • YYAI 0
  • CTXR 3
  • Target Price
  • YYAI N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • YYAI 190.5K
  • CTXR 7.0M
  • Earning Date
  • YYAI 08-05-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • YYAI N/A
  • CTXR N/A
  • EPS Growth
  • YYAI N/A
  • CTXR N/A
  • EPS
  • YYAI N/A
  • CTXR N/A
  • Revenue
  • YYAI N/A
  • CTXR N/A
  • Revenue This Year
  • YYAI N/A
  • CTXR N/A
  • Revenue Next Year
  • YYAI N/A
  • CTXR N/A
  • P/E Ratio
  • YYAI N/A
  • CTXR N/A
  • Revenue Growth
  • YYAI N/A
  • CTXR N/A
  • 52 Week Low
  • YYAI $0.35
  • CTXR $0.65
  • 52 Week High
  • YYAI $18.96
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • YYAI 52.12
  • CTXR 78.24
  • Support Level
  • YYAI $0.75
  • CTXR $0.76
  • Resistance Level
  • YYAI $0.94
  • CTXR $1.45
  • Average True Range (ATR)
  • YYAI 0.10
  • CTXR 0.24
  • MACD
  • YYAI 0.00
  • CTXR 0.11
  • Stochastic Oscillator
  • YYAI 35.07
  • CTXR 98.53

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: